Home/Filings/4/0001567619-18-007097
4//SEC Filing

Eastman Ronald W 4

Accession 0001567619-18-007097

CIK 0001594337other

Filed

Nov 28, 7:00 PM ET

Accepted

Nov 29, 12:50 PM ET

Size

12.8 KB

Accession

0001567619-18-007097

Insider Transaction Report

Form 4
Period: 2018-11-27
Eastman Ronald W
Director10% Owner
Transactions
  • Disposition to Issuer

    Director Stock Option (Right to Buy)

    2018-11-27$12.50/sh20,000$250,0000 total
    Exercise: $7.19Exp: 2025-12-17Common Stock (20,000 underlying)
  • Disposition from Tender

    Common Stock

    2018-11-27$12.50/sh9,353,304$116,916,3000 total(indirect: See Footnote)
  • Disposition to Issuer

    Director Stock Option (Right to Buy)

    2018-11-27$12.50/sh15,000$187,5000 total
    Exercise: $4.59Exp: 2026-12-21Common Stock (15,000 underlying)
  • Disposition to Issuer

    Director Stock Option (Right to Buy)

    2018-11-27$12.50/sh15,000$187,5000 total
    Exercise: $11.59Exp: 2027-11-30Common Stock (15,000 underlying)
Footnotes (3)
  • [F1]Pursuant to the Agreement and Plan of Merger, dated as of October 11, 2018 (the "Merger Agreement"), between Corium International, Inc. (the "Company"), Gurnet Holding Company ("Parent") and Gurnet Merger Sub, Inc., a wholly-owned subsidiary of Parent ("Merger Sub"), Merger Sub was merged with and into the Company, with the Company continuing as the surviving corporation and a wholly-owned subsidiary of Parent (the "Merger"). Pursuant to the Merger Agreement, at the effective time of the Merger, each issued and outstanding share of common stock, par value $0.001 per share, of the Company (each, a "Share") was converted into the right to receive (i) $12.50 per Share in cash, plus (ii) one non-transferable contingent value right per Share, which represents the contractual right to receive $0.50 per Share in cash (a "CVR").
  • [F2]The securities are held of record by Essex Woodlands Health Ventures Fund VII, L.P. (the "Fund"). The Reporting Person may be deemed to share voting and investment power over securities held by the Fund.
  • [F3]Pursuant to the Merger Agreement, at the effective time of the Merger, each option to purchase Shares that was vested and outstanding was cancelled and converted into the right to receive (i) an amount in cash equal to the product of (x) the number of vested Shares issuable under such option multiplied by (y) the excess of (A) $12.50 over (B) the per share exercise price of such option, plus (ii) one CVR for each Share issuable under such option. This option is fully vested.

Documents

1 file

Issuer

Corium International, Inc.

CIK 0001594337

Entity typeother

Related Parties

1
  • filerCIK 0001597585

Filing Metadata

Form type
4
Filed
Nov 28, 7:00 PM ET
Accepted
Nov 29, 12:50 PM ET
Size
12.8 KB